6JPB
Rabbit Cav1.1-Diltiazem Complex
6JPB の概要
| エントリーDOI | 10.2210/pdb6jpb/pdb |
| EMDBエントリー | 9869 |
| 分子名称 | Voltage-dependent L-type calcium channel subunit alpha-1S, CALCIUM ION, 1,2-Distearoyl-sn-glycerophosphoethanolamine, ... (14 entities in total) |
| 機能のキーワード | membrane protein complex modulated by fda approved drug., membrane protein |
| 由来する生物種 | Oryctolagus cuniculus (Rabbit) 詳細 |
| タンパク質・核酸の鎖数 | 5 |
| 化学式量合計 | 473151.15 |
| 構造登録者 | |
| 主引用文献 | Zhao, Y.,Huang, G.,Wu, J.,Wu, Q.,Gao, S.,Yan, Z.,Lei, J.,Yan, N. Molecular Basis for Ligand Modulation of a Mammalian Voltage-Gated Ca2+Channel. Cell, 177:1495-1506.e12, 2019 Cited by PubMed Abstract: The L-type voltage-gated Ca (Ca) channels are modulated by various compounds exemplified by 1,4-dihydropyridines (DHP), benzothiazepines (BTZ), and phenylalkylamines (PAA), many of which have been used for characterizing channel properties and for treatment of hypertension and other disorders. Here, we report the cryoelectron microscopy (cryo-EM) structures of Ca1.1 in complex with archetypal antagonistic drugs, nifedipine, diltiazem, and verapamil, at resolutions of 2.9 Å, 3.0 Å, and 2.7 Å, respectively, and with a DHP agonist Bay K 8644 at 2.8 Å. Diltiazem and verapamil traverse the central cavity of the pore domain, directly blocking ion permeation. Although nifedipine and Bay K 8644 occupy the same fenestration site at the interface of repeats III and IV, the coordination details support previous functional observations that Bay K 8644 is less favored in the inactivated state. These structures elucidate the modes of action of different Ca ligands and establish a framework for structure-guided drug discovery. PubMed: 31150622DOI: 10.1016/j.cell.2019.04.043 主引用文献が同じPDBエントリー |
| 実験手法 | ELECTRON MICROSCOPY (2.9 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






